120 related articles for article (PubMed ID: 15991973)
1. IBC's conference on antibody engineering; new technology, application and commercialisation.
Wilton J; Braddock P; Smith S; Smith S
Expert Opin Investig Drugs; 1998 May; 7(5):835-8. PubMed ID: 15991973
[TBL] [Abstract][Full Text] [Related]
2. IBC's 23rd Annual Antibody Engineering, 10th Annual Antibody Therapeutics international conferences and the 2012 Annual Meeting of The Antibody Society: December 3-6, 2012, San Diego, CA.
Klöhn PC; Wuellner U; Zizlsperger N; Zhou Y; Tavares D; Berger S; Zettlitz KA; Proetzel G; Yong M; Begent RH; Reichert JM
MAbs; 2013; 5(2):178-201. PubMed ID: 23575266
[TBL] [Abstract][Full Text] [Related]
3. IBC's 22nd Annual Antibody Engineering and 9th Annual Antibody Therapeutics International Conferences and the 2011 Annual Meeting of The Antibody Society, December 5-8, 2011, San Diego, CA.
Nilvebrant J; Dunlop DC; Sircar A; Wurch T; Falkowska E; Reichert JM; Helguera G; Piccione EC; Brack S; Berger S
MAbs; 2012; 4(2):153-81. PubMed ID: 22453091
[TBL] [Abstract][Full Text] [Related]
4. IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5-9, 2010, San Diego, CA USA.
Arnett SO; Teillaud JL; Wurch T; Reichert JM; Dunlop C; Huber M
MAbs; 2011; 3(2):133-52. PubMed ID: 21304271
[TBL] [Abstract][Full Text] [Related]
5. IBC's 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CA.
Marquardt J; Begent RH; Chester K; Huston JS; Bradbury A; Scott JK; Thorpe PE; Veldman T; Reichert JM; Weiner LM
MAbs; 2012; 4(6):648-52. PubMed ID: 23007482
[TBL] [Abstract][Full Text] [Related]
6. Engineered antibodies take center stage.
Huston JS; George AJ
Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
[TBL] [Abstract][Full Text] [Related]
7. Antibody engineering--IBC's Tenth International Conference. 6-9 December 1999, La Jolla, CA, USA.
Carter P
IDrugs; 2000 Mar; 3(3):259-61. PubMed ID: 16103927
[TBL] [Abstract][Full Text] [Related]
8. Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA.
Larrick JW; Alfenito MR; Scott JK; Parren PW; Burton DR; Bradbury AR; Lemere CA; Messer A; Huston JS; Carter PJ; Veldman T; Chester KA; Schuurman J; Adams GP; Reichert JM
MAbs; 2016; 8(8):1425-1434. PubMed ID: 27557809
[TBL] [Abstract][Full Text] [Related]
9. IBC's Drug Discovery Technology - Europe 2001. 23-26 April 2001, Stuttgart, Germany.
Kubinyi H
IDrugs; 2001 Jul; 4(7):776-82. PubMed ID: 15995933
[TBL] [Abstract][Full Text] [Related]
10. Antibody Engineering & Therapeutics, the annual meeting of The Antibody Society December 7-10, 2015, San Diego, CA, USA.
Pauthner M; Yeung J; Ullman C; Bakker J; Wurch T; Reichert JM; Lund-Johansen F; Bradbury AR; Carter PJ; Melis JP
MAbs; 2016; 8(3):617-52. PubMed ID: 26909869
[TBL] [Abstract][Full Text] [Related]
11.
André AS; Moutinho I; Dias JNR; Aires-da-Silva F
Front Microbiol; 2022; 13():962124. PubMed ID: 36225354
[TBL] [Abstract][Full Text] [Related]
12. Antibody engineering--IBC's 15th Annual International Conference. 30 November-3 December 2004, San Diego, CA, USA.
Haurum JS
IDrugs; 2005 Feb; 8(2):91-3. PubMed ID: 15696403
[No Abstract] [Full Text] [Related]
13. Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CA.
Parren PW; Burton DR; Bradbury A; Huston JS; Carter PJ; Veldman T; Chester KA; Larrick JW; Alfenito MR; Scott JK; Weiner LM; Adams GP; Reichert JM
MAbs; 2015; 7(6):981-8. PubMed ID: 26421752
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Antibodies by Phage Display.
Shim H
Curr Pharm Des; 2016; 22(43):6538-6559. PubMed ID: 27669967
[TBL] [Abstract][Full Text] [Related]
15. IBC's conference on pulmonary hypertension: new understanding for therapeutic development.
Bialecki RA
Expert Opin Investig Drugs; 1998 Apr; 7(4):653-8. PubMed ID: 15992001
[TBL] [Abstract][Full Text] [Related]
16. Antibody Engineering--IBC's 17th annual international conference. Antibody engineering and immunotherapeutics for the 21st century.
Bradbury A
IDrugs; 2007 Mar; 10(3):169-72. PubMed ID: 17351868
[No Abstract] [Full Text] [Related]
17. IBC's 5th Annual Conference on Blood Substitutes.
Shorr RG
Expert Opin Investig Drugs; 1998 Feb; 7(2):283-91. PubMed ID: 15991960
[TBL] [Abstract][Full Text] [Related]
18. TargetTalk--IBC Conference. Kinase and G protein-coupled receptor targets.
Gilchrist A
IDrugs; 2005 Jun; 8(6):479-82. PubMed ID: 15906193
[TBL] [Abstract][Full Text] [Related]
19. Empowered Antibody Therapies - IBC conference.
Herold J
IDrugs; 2010 Oct; 13(10):698-700. PubMed ID: 20878591
[TBL] [Abstract][Full Text] [Related]
20. Strategies and techniques for identification of novel bioactive compounds--CHI's second annual conference. 7-9 October 1998, Zurich, Switzerland.
Kubinyi H
IDrugs; 1998 Dec; 1(8):883-6. PubMed ID: 16196479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
